Prince Pharmaceutical Co., Ltd.
Prince Pharmaceutical Co., Ltd. manufactures and sells vitamin B1 active pharmaceutical ingredients (APIs) in Taiwan, Japan, Korea, and internationally. The company also offers health food and medicines; vitamin c tablets, vitamin b complex tablets, natto and rhodiola extract capsules, probiotic sachets, and plant extract capsules; and API products comprising felbinac, aldioxa, tulobuterol, ufena… Read more
Market Cap & Net Worth: Prince Pharmaceutical Co., Ltd. (6935)
Prince Pharmaceutical Co., Ltd. (TWO:6935) has a market capitalization of $31.55 Million (NT$1.04 Billion) as of March 19, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #28208 globally and #1782 in its home market, demonstrating a -1.93% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Prince Pharmaceutical Co., Ltd.'s stock price NT$27.90 by its total outstanding shares 37410000 (37.41 Million).
Prince Pharmaceutical Co., Ltd. Market Cap History: 2026 to 2026
Prince Pharmaceutical Co., Ltd.'s market capitalization history from 2026 to 2026. Data shows growth from $31.55 Million to $31.55 Million (0.00% CAGR).
Prince Pharmaceutical Co., Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Prince Pharmaceutical Co., Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 6935 by Market Capitalization
Companies near Prince Pharmaceutical Co., Ltd. in the global market cap rankings as of March 19, 2026.
Key companies related to Prince Pharmaceutical Co., Ltd. by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Prince Pharmaceutical Co., Ltd. Historical Marketcap From 2026 to 2026
Between 2026 and today, Prince Pharmaceutical Co., Ltd.'s market cap moved from $31.55 Million to $ 31.55 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$31.55 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Prince Pharmaceutical Co., Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $31.55 Million USD |
| MoneyControl | $31.55 Million USD |
| MarketWatch | $31.55 Million USD |
| marketcap.company | $31.55 Million USD |
| Reuters | $31.55 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.